IL13RA2 and breast cancer: By further analyzing our previously published gene expression microarray data from these cell lines (14, 29), we found that both IL13Rα2 and INHBA exhibit increased expression levels in metastatic compared to non-metastatic breast cancer cells and that overexpression of both genes can similarly predict worse DMFS of patients with grade 3 tumors.